SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
2.19
-0.02 (-0.90%)
At close: Aug 15, 2025, 3:59 PM
2.21
0.91%
After-hours: Aug 15, 2025, 07:52 PM EDT
SAB Biotherapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 3.69M | 5.64M | 8.9M | 9.17M | 17.24M | 14.03M | 56.57M | 2.43M | 7.77M | 13.06M | 15.05M | 8.33M | 16.62M | 22.41M | 33.21M | 667.87K | 10.23M | 858.05K |
Short-Term Investments | 2.02M | 7.21M | 11.86M | 21.23M | 20.08M | 30.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 1.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 116.16M | 116.16M | 116.15M |
Other Long-Term Assets | 417.49K | 449.79K | 482.1K | 514.41K | 521.72K | 554.03K | 350.23K | 371.19K | 434K | 434K | 467.69K | 501.39K | 535.08K | n/a | n/a | n/a | -116.16M | n/a |
Receivables | n/a | 21.39K | 54.95K | 97.05K | 224.92K | 193.23K | n/a | n/a | 364.12K | 763.12K | 5.56M | 12.94M | 9.61M | 11.79M | 8.01M | n/a | 17.11M | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.59M | 3.42M | 2.98M | 2.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.34M | n/a | n/a | n/a |
Total Current Assets | 9.31M | 16.3M | 23.79M | 32.54M | 39.58M | 46.95M | 58.91M | 3.13M | 9.01M | 15.03M | 22.1M | 22.18M | 27.75M | 36.17M | 48.42M | 770.62K | 27.77M | 1.12M |
Property-Plant & Equipment | 20.4M | 21.37M | 19.92M | 20.75M | 21.79M | 22.63M | 24.68M | 24.84M | 26M | 27.21M | 28.34M | 29.82M | 30.87M | 31.3M | 30.95M | n/a | 26.44M | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 20.82M | 21.82M | 20.4M | 21.26M | 22.31M | 24.42M | 25.03M | 25.21M | 26.44M | 27.64M | 28.81M | 30.33M | 31.4M | 31.3M | 30.95M | 116.16M | 26.44M | 116.15M |
Total Assets | 30.13M | 38.12M | 44.2M | 53.8M | 61.89M | 71.37M | 83.94M | 28.34M | 35.44M | 42.67M | 50.9M | 52.51M | 59.15M | 67.47M | 79.37M | 116.93M | 54.21M | 117.27M |
Account Payables | 2.62M | 2.52M | 1.69M | 1.3M | 1.17M | 1.24M | 945.93K | 1.08M | 1.4M | 1.44M | 3.68M | 5.48M | 4.94M | 4.98M | 4.46M | n/a | 5.5M | n/a |
Deferred Revenue | n/a | n/a | n/a | 114.7K | 114.7K | 377.83K | 1.32M | 1.63M | 2.89M | 2.94M | n/a | n/a | n/a | n/a | 100K | n/a | 100K | n/a |
Short-Term Debt | 963.22K | 138.55K | 811.84K | 524.74K | 615.82K | 835.47K | 1.05M | 541.64K | 784.88K | 444.48K | 772.66K | 1.38M | 1.33M | 1.33M | 186.06K | n/a | 24.14K | n/a |
Other Current Liabilities | 2.01M | n/a | 4.94M | 220.76K | 1.01M | 1.28M | 4.49M | 4.43M | 4.22M | 923.16K | 8.1M | 6.32M | 6.06M | 8.85M | 8.53M | n/a | 587.78K | 80K |
Total Current Liabilities | 10.68M | 9.65M | 7.98M | 8.82M | 7.55M | 8.3M | 10.81M | 9.21M | 11.01M | 13.67M | 14.99M | 17.1M | 16.14M | 18.26M | 24.68M | 322.38K | 10.2M | 80K |
Long-Term Debt | 5.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 541.64K | 541.64K | 541.64K | n/a | n/a | n/a | n/a | n/a | 25.01K | n/a |
Other Long-Term Liabilities | 1.98M | 1.35M | 6.39M | 4.08M | 4.09M | 6.31M | 11.77M | 417.1K | 595.86K | 238.34K | 320.93K | 357.52K | 1.14M | 2.87M | 10.72M | 9.75M | n/a | 7.8M |
Total Long-Term Liabilities | 7.44M | 7.06M | 10.25M | 8.08M | 8.22M | 10.24M | 15.83M | 3.87M | 4.72M | 4.6M | 4.85M | 4.78M | 5.9M | 7.96M | 16.14M | 9.75M | 5.76M | 7.8M |
Total Liabilities | 18.11M | 16.71M | 18.23M | 16.89M | 15.77M | 18.55M | 26.64M | 13.08M | 15.73M | 18.27M | 19.85M | 21.88M | 22.03M | 26.21M | 40.82M | 10.07M | 15.95M | 7.88M |
Total Debt | 6.42M | 6.78M | 4.67M | 4.52M | 5.34M | 5.45M | 5.91M | 4.65M | 4.9M | 5.46M | 5.93M | 5.8M | 6.09M | 6.41M | 6.74M | n/a | 6.92M | n/a |
Common Stock | 936.00 | 936.00 | 935.00 | 929.00 | 929.00 | 929.00 | 929.00 | 5.29K | 5.29K | 5.09K | 5.09K | 4.36K | 4.36K | 4.35K | 4.35K | 116.15M | 3.52K | 104.39M |
Retained Earnings | -139.48M | -129.37M | -124.17M | -112.77M | -102.42M | -95.09M | -90.06M | -67.21M | -62.1M | -55.22M | -47.87M | -40M | -32.92M | -28.14M | -29.13M | -9.29M | -13.52M | 2.96M |
Comprehensive Income | -15.8K | -111.59K | -135.41K | 52.13K | -31.35K | -63.45K | 26.42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 12.02M | 21.41M | 25.97M | 36.9M | 46.12M | 52.82M | 57.3M | 15.26M | 19.72M | 24.4M | 31.06M | 30.62M | 37.12M | 41.26M | 38.55M | 106.86M | 38.26M | 109.39M |
Total Investments | 2.02M | 7.21M | 11.86M | 21.23M | 20.08M | 31.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 116.16M | 116.16M | 116.15M |